Pictet Asset Management Holding SA Has $395,000 Holdings in Enovis Co. (NYSE:ENOV)

Pictet Asset Management Holding SA raised its stake in Enovis Co. (NYSE:ENOV) by 27.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,993 shares of the company’s stock after buying an additional 1,932 shares during the quarter. Pictet Asset Management Holding SA’s holdings in Enovis were worth $395,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Raymond James Financial Inc. acquired a new position in Enovis during the fourth quarter valued at approximately $16,407,000. Boston Partners boosted its position in shares of Enovis by 27.1% during the fourth quarter. Boston Partners now owns 1,048,532 shares of the company’s stock worth $46,034,000 after purchasing an additional 223,816 shares in the last quarter. Artemis Investment Management LLP grew its holdings in shares of Enovis by 35.4% in the 4th quarter. Artemis Investment Management LLP now owns 665,868 shares of the company’s stock valued at $29,218,000 after buying an additional 174,116 shares during the period. DAVENPORT & Co LLC increased its position in shares of Enovis by 6.0% in the 4th quarter. DAVENPORT & Co LLC now owns 2,782,341 shares of the company’s stock valued at $121,181,000 after buying an additional 157,216 shares in the last quarter. Finally, Sei Investments Co. raised its stake in Enovis by 51.0% during the 4th quarter. Sei Investments Co. now owns 453,241 shares of the company’s stock worth $19,888,000 after buying an additional 153,006 shares during the period. Institutional investors own 98.45% of the company’s stock.

Analyst Ratings Changes

Separately, Needham & Company LLC reissued a “buy” rating and set a $64.00 price objective on shares of Enovis in a research report on Wednesday.

Enovis Stock Up 11.8 %

Shares of Enovis stock opened at $34.29 on Thursday. The business’s 50 day simple moving average is $39.40 and its 200 day simple moving average is $42.70. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.12 and a current ratio of 2.27. Enovis Co. has a 52-week low of $29.32 and a 52-week high of $61.92. The firm has a market cap of $1.95 billion, a PE ratio of -15.66 and a beta of 1.86.

Enovis (NYSE:ENOV) last released its earnings results on Wednesday, February 26th. The company reported $0.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.92 by $0.06. Enovis had a positive return on equity of 4.39% and a negative net margin of 5.95%. The business had revenue of $560.98 million for the quarter, compared to the consensus estimate of $555.14 million. On average, analysts predict that Enovis Co. will post 2.79 earnings per share for the current fiscal year.

Enovis Profile

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.